162 related articles for article (PubMed ID: 18511375)
1. [Chemotherapy and renal toxicity].
Launay-Vacher V; Isnard-Bagnis C; Janus N; Karie S; Deray G
Bull Cancer; 2008 May; 95 FMC Onco():F96-103. PubMed ID: 18511375
[TBL] [Abstract][Full Text] [Related]
2. Toxicities of the platinum antineoplastic agents.
Markman M
Expert Opin Drug Saf; 2003 Nov; 2(6):597-607. PubMed ID: 14585068
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
Cornelison TL; Reed E
Gynecol Oncol; 1993 Aug; 50(2):147-58. PubMed ID: 8375728
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of anticancer drugs--an underestimated problem?
Lameire N; Kruse V; Rottey S
Acta Clin Belg; 2011; 66(5):337-45. PubMed ID: 22145268
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of common drugs used by urologists.
Bennett WM; Porter GA
Urol Clin North Am; 1990 Feb; 17(1):145-56. PubMed ID: 2407013
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity from chemotherapy: prevention and management.
Vogelzang NJ
Oncology (Williston Park); 1991 Oct; 5(10):97-102, 105; disc. 105, 109-11. PubMed ID: 1838278
[TBL] [Abstract][Full Text] [Related]
9. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
Ali BH; Al Moundhri MS
Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of platinum compounds.
Hartmann JT; Lipp HP
Expert Opin Pharmacother; 2003 Jun; 4(6):889-901. PubMed ID: 12783586
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V; Etessami R; Janus N; Spano JP; Ray-Coquard I; Oudard S; Gligorov J; Pourrat X; Beuzeboc P; Deray G; Morere JF;
Lung; 2009; 187(1):69-74. PubMed ID: 18941834
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.
Iwasaki K; Obara W; Kato Y; Takata R; Tanji S; Fujioka T
Jpn J Clin Oncol; 2013 Feb; 43(2):193-9. PubMed ID: 23275643
[TBL] [Abstract][Full Text] [Related]
14. Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.
Morís G; Ribacoba R; González C
J Neurol; 2007 Apr; 254(4):534-5. PubMed ID: 17361348
[No Abstract] [Full Text] [Related]
15. Gemox: a widely useful therapy against solid tumors-review and personal experience.
Meriggi F; Zaniboni A
J Chemother; 2010 Oct; 22(5):298-303. PubMed ID: 21123151
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and management of nephrotoxicity from anti-cancer agents].
Miyazaki J; Kawai K
Nihon Rinsho; 2003 Jun; 61(6):973-7. PubMed ID: 12806945
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function.
Massari C; Brienza S; Rotarski M; Gastiaburu J; Misset JL; Cupissol D; Alafaci E; Dutertre-Catella H; Bastian G
Cancer Chemother Pharmacol; 2000; 45(2):157-64. PubMed ID: 10663631
[TBL] [Abstract][Full Text] [Related]
18. Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!
Marx GM; Steer CB; Harper P; Pavlakis N; Rixe O; Khayat D
J Clin Oncol; 2002 Mar; 20(6):1446-8. PubMed ID: 11896090
[No Abstract] [Full Text] [Related]
19. [Renal toxicity with a gemcitabine-cisplatin combination in lung cancer].
Margery J; Vaylet F; Guigay J; Grassin F; Morel V; L'Her P
Presse Med; 2002 May; 31(17):794. PubMed ID: 12148362
[No Abstract] [Full Text] [Related]
20. [The kidney in children under chemotherapy].
Cachat F; Guignard JP
Rev Med Suisse Romande; 1996 Dec; 116(12):985-93. PubMed ID: 9026889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
